EX-FILING FEES 4 ea177310ex-fee_abvcbio.htm FILING FEE TABLE

Exhibit 107

 

CALCULATION OF FILING FEE TABLES

 

FORM S-1

 

ABVC BioPharma, Inc.

 

Table 1: Newly Registered Securities

 

Security
Type		   Security
Class Title		   Fee
Calculation
or Carry
Forward
Rule (1)		     Amount
Registered		     Proposed
Maximum
Offering
Price Per
Unit		     Maximum
Aggregate
Offering
Price		     Fee Rate     Amount of
Registration
Fee (3)		  
Equity   Common Stock, $0.001par value, issuable upon conversion of the Note                   $       $ 3,175,000       .0001102     $ 349.89  
Equity   Common Stock, $0.001 par value, issuable upon exercise of the Warrant     457(c) (2)     5,291,677     $ 0.66     $ 3,492,506.82       .0001102     $ 384.87  
Equity   Common Stock, $0.001 par value, issuable upon exercise of the PA Warrant     457(c) (2)     211,667     $ 0.66     $ 139,700.22       .0001102     $ 15.39  
Total Offering Amounts             $ 6,807,207.04       .0001102     $ 750.15  
Total Fees Previously Paid                             $ -  
Total Fee Offsets                             $ -  
Net Fee Due                             $ 750.15  

 

(1) Pursuant to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares as may from time to time become issuable by reason of stock splits, distributions, recapitalizations or other similar transactions.
   
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act. The proposed maximum offering price per share is estimated to be $0.66, based on the average of the high ($0.69) and low ($0.63) sales prices of the Common Stock as reported by the Nasdaq Capital Market on April 20, 2023. 
   
(3) The fee is calculated by multiplying the aggregate offering amount by 0.0001102 pursuant to Section 6(b) of the Securities Act.